Edition:
United Kingdom

Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

585JPY
20 Nov 2017
Change (% chg)

¥14 (+2.45%)
Prev Close
¥571
Open
¥571
Day's High
¥587
Day's Low
¥567
Volume
339,300
Avg. Vol
268,082
52-wk High
¥742
52-wk Low
¥491

Summary

Name Age Since Current Position

Ryoichi Nagata

57 2016 Chairman of the Board, President, Group Chief Executive Officer, Chairman of Subsidiary, Representative Director

Toshihiko Seki

61 2016 Vice Chairman of the Board, Global Chief Financial Officer, Representative Director

Koichiro Fukuzaki

57 2016 Vice Chairman of the Board

Takeshi Yamakawa

49 2011 Chief Executive Officer of Subsidiary, Director

Ken Takanashi

53 2017 Chief Operating Officer, Vice President, Representative Director

Shuichi Kanazashi

2014 Managing Director, President of TR Business Company

Hidenobu Sameshima

58 2012 Managing Director, Director of Safety Research Institute

Hideyuki Hirama

39 2016 Executive Director

Shinji Nitanda

47 2016 Executive Director

Kazumi Uchi

58 2012 Executive Director

Hideshi Tsusaki

47 2014 Senior Director of Global Sales Unit, Director

Takayuki Sukamoto

62 2013 Executive Officer, Director of Asia Sales in Main Sales Supervision Unit, Manager of Pharmacology Center of Safety Research Institute

Takeyuki Genba

Executive Officer, Deputy Chief Director of TR Business, Director of TR Business

Shunji Haruta

Executive Officer, Deputy Chief Director of TR Business, Director of NDS Business, Director of Sales Strategy

Terumasa Hirai

Executive Officer, Deputy Director of Safety Research Institute

Tomoaki Honda

1 Executive Officer

Hiroyuki Izumi

Executive Officer, Deputy Director of Safety Research Institute, Manager of Planning Office of Safety Research Institute

Ralph Lynn

Executive Officer, Chief Director of Global Business Development

Takahiro Nakamura

Executive Officer, Manager Safety Research Institute

Yojiro Ohshima

Executive Officer

Masahiro Uto

Executive Officer, Manager of Drug Metabolism Analysis Center in CR Business Company

Satoshi Matsumoto

48 2016 Manager of President's (Global CEO Office) Office, Director

Nobuaki Sakashita

59 2013 Director of Clinical Business, Director

Shinichi Fukumoto

Non-Executive Independent Director

Takashi Yamashita

Non-Executive Independent Director

Yasutaka Kamata

Assistant Manager of General Affairs and Human Resources

Biographies

Name Description

Ryoichi Nagata

Mr. Ryoichi Nagata was named Chairman of the Board, President, Group Chief Executive Officer and Representative Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., as well as Chairman of a subsidiary, SNBL U.S.A., Ltd., effective June 29, 2016. He joined the Company in April 1983. His previous titles include Chief Director of Global Business Development, President of Translational Research Company, Senior Managing Director and President of Preclinical Business Company. He used to serve as Chairman of the Board and Representative Director in a Japan-based subsidiary.

Toshihiko Seki

Mr. Toshihiko Seki was named Vice Chairman of the Board, Global Chief Financial Officer and Representative Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. effective June 29, 2016. He joined the Company in February 2003. His previous titles include Director of Tokyo Management, Manager of Business Administration Office and Deputy Chief Senior Director of Operation of Accounting in the Company. He worked for Denny's Japan Co., Ltd., Sanrio Co., Ltd. and NAC Co., Ltd. before he joined the Company.

Koichiro Fukuzaki

Mr. Koichiro Fukuzaki was named Vice Chairman of the Board in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. effective June 29, 2016. He joined the Company in March 1988. His previous titles include Director of Safety Research Institute, President of Preclinical Business Company, Director of Research Management, Vice President and President of NDS Business Company. He used to work for UBE INDUSTRIES, LTD.

Takeshi Yamakawa

Mr. Takeshi Yamakawa has been serving as Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD, as well as Chief Executive Officer in a subsidiary SNBL Clinical Pharmacy Center,Inc., since June 2011. He is also Vice Chairman of another subsidiary, SNBL U.S.A.,Ltd. He joined the Company in October 2010. His previous titles include Executive Officer and Managing Executive Officer. Mr. Yamakawa used to work for Ministry of Internal Affairs and Communications, as well as Ministry of Foreign Affairs of Japan.

Ken Takanashi

Mr. Ken Takanashi has been serving as Chief Operating Officer, Vice President and Representative Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. since June 29, 2017. He joined the Company in December 2002. His previous titles include Deputy Chief Director of Global Business Development, Vice President of Translational Research Company, President of TR Business Company, Vice President of NDS Business Company, Deputy Director of Business Planning, Manager of New Business Office and President of Translational Research Company. He previously worked for Mitsubishi Corporation and SUASA KRISTAL(M)BERHAD before joining the Company. He is a Chartered Public Accountant.

Shuichi Kanazashi

Hidenobu Sameshima

Mr. Hidenobu Sameshima has been serving as Managing Director and Director of Safety Research Institute in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD, since May 2012. He is also serving as Director in its subsidiary SNBL U.S.A., Ltd. He joined the Company in March 1989. He used to serve as Vice President of Contract Research Business, Managing Executive Officer, President of Contract Research Business Company, Chief Senior Director of Sales, Senior Managing Executive Officer and Director of Compliance Promotion in the Company. He previously worked for a Japan-based company.

Hideyuki Hirama

Mr. Hideyuki Hirama was named Executive Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. effective June 29, 2016. He will be also in charge of Business Strategy & SMO Business of the Company. He joined the Company in February 2004. He used to be Executive Officer in the Company, as well as Senior Vice President and Chief Financial Officer in two subsidiaries, SNBL U.S.A., Ltd. and SNBL Clinical Pharmacology Center, Inc. He worked for The Industrial Bank of Japan, Limited, before joining the Company.

Shinji Nitanda

Mr. Shinji Nitanda was named Executive Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. effective June 29, 2016. He will be also in charge of Special Assignment of the Company. He joined the Company in May 2002. He previously served as Chief Director of Administration and Chief Director of Business Management in the Company. He used to work for another company.

Kazumi Uchi

Mr. Kazumi Uchi has been serving as Executive Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. since June 28, 2012. He is also in charge of Finance in the Company. He used to work for THE KAGOSHIMA BANK, LTD.

Hideshi Tsusaki

Takayuki Sukamoto

Mr. Takayuki Sukamoto has been serving as Executive Officer, Director of Asia Sales in Main Sales Supervision Unit and Manager of Pharmacology Center of Safety Research Institute in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD since 2013. He is also serving as Director in a subsidiary, SNBL U.S.A., Ltd. Mr. Sukamoto joined the Company in November 2002. He previously served as Director of Asia Sales in Main Global Business Development Unit, Director of Safety Research Institute and Director of the Company. He used to work for other companies.

Takeyuki Genba

Shunji Haruta

Terumasa Hirai

Tomoaki Honda

Hiroyuki Izumi

Ralph Lynn

Takahiro Nakamura

Yojiro Ohshima

Masahiro Uto

Satoshi Matsumoto

Mr. Satoshi Matsumoto was named Manager of President's (Global CEO Office) Office and Director in SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. effective June 29, 2016. He joined the Company in June 1999. His previous titles include Executive Officer, Director of Clinical Business and Chief Director of HR in the Company. He used to work for Dainippon Sumitomo Pharma Co., Ltd. and another company.

Nobuaki Sakashita

Mr. Nobuaki Sakashita has been serving as Director of Clinical Business and Director of SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. since June 27, 2013. He joined the Company in May 2005. He used to be Executive Officer and Deputy Director of CRO Business in the Company. He worked for three other companies, including PAREXEL, Japan.

Shinichi Fukumoto

Takashi Yamashita

Yasutaka Kamata